PicturaBio
PrivateLast Round
Grant
May 24, 2023
Total Funding Raised
$9.65M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PicturaBio is a medical technology company that develops a rapid pathogen detection platform using single-molecule fluorescent microscopy and machine learning to identify infectious diseases at the point of care.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Devices, Biotechnology, Defense Tech
Business Model
B2G
Customer Profile
Government Contracts, Hardware + Subscription, Usage-Based SaaS, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PicturaBio Comparables
Compare PicturaBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Abbott Laboratories | 69% | |
| Pattern Bioscience | 67% | |
| Neomend | 64% |
PicturaBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 24, 2023 | ||||
| Grant | Oct 17, 2022 | ||||
| Pre Seed | Feb 15, 2022 |
PicturaBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Flu Lab | Pre Seed |
| IQ Capital | Pre Seed |
| Innovate UK | Grant |
| Defence and Security Accelerator | Grant |
| Science Creates Ventures | Pre Seed |
| Ahren Innovation Capital | Pre Seed |
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 10, 2026
Open roles increased to 4, 2.7x the trailing average.
- May 24, 2023
$620K raised from Defence and Security Accelerator.
PicturaBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PicturaBio's valuation, stock price, and market status.
Is Pictura Bio a public or private company?
Pictura Bio is a private company.
What is the current stock price of Pictura Bio?
Pictura Bio is a private company with no public stock price. Caplight tracks Pictura Bio's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Pictura Bio worth (valuation)?
Valuation information for Pictura Bio is not publicly available.
Can I buy Pictura Bio stock?
Pictura Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Pictura Bio's last funding round?
Pictura Bio's most recent funding round was Grant on May 24, 2023.
Who are the main investors in Pictura Bio?
Key investors in Pictura Bio include IQ Capital, Ahren Innovation Capital.
Will Pictura Bio IPO soon?
No public IPO plans have been announced for Pictura Bio.
How can I track Pictura Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pictura Bio's secondary market activity and sign up for updates.